Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,389 | 105,017 | 203,234 | 129,975 | 168,004 |
| Marketable Securities | 180,743 | 193,615 | 149,884 | 133,098 | 99,525 |
| Receivables | 11,062 | 9,581 | 9,281 | 7,862 | 7,928 |
| Inventories | 2,011 | 1,652 | 970 | 346 | 100 |
| TOTAL | $285,447 | $317,836 | $370,920 | $278,570 | $280,867 |
| Non-Current Assets | |||||
| PPE Net | 2,357 | 2,592 | 2,814 | 3,046 | 3,240 |
| Investments And Advances | 39,371 | 48,856 | 31,373 | 2,016 | 2,022 |
| Other Non-Current Assets | 10,412 | 10,727 | 11,034 | 11,331 | 11,616 |
| TOTAL | $52,140 | $62,175 | $45,221 | $16,393 | $16,878 |
| Total Assets | $337,587 | $380,011 | $416,141 | $294,963 | $297,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,422 | 1,888 | 1,694 | 985 | 3,068 |
| Accrued Expenses | 46,591 | 45,979 | 43,783 | 40,878 | 32,421 |
| Other current liabilities | 1,473 | 628 | 1,224 | 500 | 1,077 |
| TOTAL | $52,630 | $50,570 | $49,699 | $46,350 | $39,202 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 297 | 297 | 1,287 | 2,341 | 1,053 |
| Other Non-Current Liabilities | 201,187 | 199,642 | 198,103 | 196,647 | 195,194 |
| TOTAL | $201,187 | $199,642 | $200,295 | $198,839 | $198,673 |
| Total Liabilities | $253,817 | $250,212 | $249,994 | $245,189 | $237,875 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,909 | 4,901 | 4,877 | 4,372 | 4,188 |
| Common Shares | 7 | 7 | 7 | 7 | 6 |
| Retained earnings | -1,026,190 | -972,695 | -926,269 | -873,338 | -824,691 |
| Other shareholders' equity | 603 | 891 | -420 | -37 | -30 |
| TOTAL | $83,770 | $129,799 | $166,147 | $49,774 | $59,870 |
| Total Liabilities And Equity | $337,587 | $380,011 | $416,141 | $294,963 | $297,745 |